$16.31-5.53% · 3M
Moving avg
1W-0.76%
1M-2.25%
3M-1.06%
6M+3.39%
YTD+30.86%
1Y+52.53%
3Y+45.71%
5Y+9.36%
52-week range
$8.6385% of range$17.68
Company health
Value4/6
Growth1/6
Profitability1/6
Health2/6
Dividend3/6
Bull vs bear
Strengths
- Pays a 2.7% dividend
Risks
- Currently unprofitable
Key statistics
Valuation
Market cap
$18.99B
Enterprise value
$33.02B
P/E ratio (TTM)
-66.65x
P/S ratio (TTM)
1.41x
EV/EBITDA
12.87x
Per share & returns
EPS (TTM)
-$0.26
Dividend yield
2.73%
Beta (1Y)
0.90
30-day change
-2.25%
Trading
Volume (24h)
4.80M
Previous close
$16.10
Shares outstanding
1.16B
About Viatris Inc.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
NASDAQ
Symbol
VTRS
Viatris Inc. is a large-cap healthcare company in the Drug Manufacturers - Specialty & Generic industry. Its shares are listed on NASDAQ (United States) and trade under the ticker VTRS.
Frequently asked questions
What is Viatris Inc.'s market cap?
Viatris Inc. (VTRS) has a market capitalization of $18.99B.
What sector is Viatris Inc. in?
Viatris Inc. operates in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry.
What exchange does VTRS trade on?
VTRS trades on NASDAQ.
Appears in
Eli Lilly and CompanyLLY
$1,216.03-0.35%
$1.15T cap
Johnson & JohnsonJNJ
$261.33+0.18%
$629.78B cap
AbbVie Inc.ABBV
$250.78+0.81%
$443.08B cap
UnitedHealth Group IncorporatedUNH
$402.12-0.86%
$365.18B cap
Roche Holding AGSWX: ROP
CHF 362.30-0.88%
$354.73B cap
Merck & Co., Inc.MRK
$134.53+1.21%
$332.26B cap
Novartis AGSWX: NOVN
CHF 123.74-0.37%
$289.30B cap
AstraZeneca PLCLON: AZN
£117.08+0.05%
$245.01B cap